Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Replicative Cell Senescence02:15

Replicative Cell Senescence

3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of integrated nested Laplace approximation to identify hot spots of methylation heterogeneity in healthy individuals from the MAMELI cohort.

Frontiers in genetics·2026
Same author

The Reasons to Get Vaccinated: A Cross-Sectional Study on HPV Vaccination Adherence in a Northern Italian University.

Vaccines·2026
Same author

Neurophenomenology, psychoneuroendocrinoimmunology and epigenetics: towards an integrative framework for understanding the health benefits of art and aesthetic experiences.

Journal of the Royal Society, Interface·2026
Same author

Healing dynamics and surgery in breast cancer: rethinking a timeless challenge in light of advancing therapies and technologies.

Journal of translational medicine·2026
Same author

Expression of antibody-drug conjugate targets in post-mortem samples of breast cancer metastases and normal tissue.

Nature communications·2025
Same author

ctDNA detectability and representativeness in seven body liquids from patients with metastatic breast cancer.

Nature communications·2025
Same journal

Mapping the 3D Chromosome Organization of a Biosynthetic Gene Cluster by Capture Hi-C (CHi-C).

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Mapping the 3D Chromosome Organization of Streptomyces by Hi-C.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

CUT&Tag Epigenomic Profiling of Biosynthetic Gene Clusters in Arabidopsis thaliana.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Rhizobium rhizogenes-Mediated Hairy Root Transformation Protocol for Lotus japonicus and Other Legumes.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Characterization of Bioactive Saponins from Sea Cucumbers.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for Functional Validation of Terpenoid Metabolic Clusters in Nicotiana benthamiana and Aspergillus oryzae.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Jun 20, 2025

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
09:14

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

Published on: August 11, 2011

15.9K

Clinical Tumor Dormancy.

Romano Demicheli1, Elia Biganzoli2

  • 1Unit of Medical Statistics, Biometry and Epidemiology, Department of Biomedical and Clinical Sciences, IBIC & DSRC, Ospedale "L. Sacco," LITA Campus, Università degli Studi di Milano, Milan, Italy. romano.demicheli@guest.unimi.it.

Methods in Molecular Biology (Clifton, N.J.)
|July 22, 2024
PubMed
Summary
This summary is machine-generated.

Tumor dormancy plays a critical role in breast cancer recurrence after mastectomy. Our research proposes a new model of cancer development, challenging the Somatic Mutation Theory and emphasizing tissue-level processes.

Keywords:
Bench to bedside gapClinical tumor dormancyComplex system dynamicsDormancy-based modelTissue level cancerogenesis

More Related Videos

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

8.2K
A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells
12:48

A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells

Published on: February 16, 2018

7.4K

Related Experiment Videos

Last Updated: Jun 20, 2025

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
09:14

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

Published on: August 11, 2011

15.9K
An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

8.2K
A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells
12:48

A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells

Published on: February 16, 2018

7.4K

Area of Science:

  • Oncology
  • Cancer Biology
  • Clinical Medicine

Background:

  • Tumor dormancy is a critical factor in cancer recurrence, particularly in breast cancer.
  • Existing models do not fully explain clinical phenomena like the mammographic paradox or late recurrences.

Purpose of the Study:

  • To summarize clinical evidence on tumor dormancy in breast cancer recurrence.
  • To propose a novel model of neoplastic development based on tumor dormancy.
  • To contrast this model with the Somatic Mutation Theory and explore alternatives like Dynamic System Theory.

Main Methods:

  • Review of clinical evidence on tumor dormancy and breast cancer recurrence.
  • Development of a dormancy-based model of neoplastic development.
  • Comparative analysis with Somatic Mutation Theory and Dynamic System Theory.

Main Results:

  • The dormancy-based model explains local and distant breast cancer recurrence post-mastectomy.
  • This model elucidates phenomena such as the mammographic paradox and ipsilateral recurrence.
  • It highlights the limitations of the Somatic Mutation Theory and offers Dynamic System Theory as an alternative.

Conclusions:

  • Tumor dormancy is a key driver of breast cancer recurrence, influencing various clinical observations.
  • A dormancy-based, tissue-level model offers a more comprehensive understanding of cancer development than the Somatic Mutation Theory.
  • This approach aims to bridge the gap between molecular biology research and clinical application in understanding dormancy.